Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
POAICompany Name
PREDICTIVE ONCOLOGY INCSector
HealthcareIndustry
Medical Instruments & SuppliesExchange
NASDAQPREDICTIVE ONCOLOGY INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
POAI - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ -1.65M | $ -9.78M | 0% |
| 3/31/2025 | $ -145.8K | $ -10.89M | 0% |
| 12/31/2024 | $ -202.61K | $ -12.66M | 0% |
| 9/30/2024 | $ 1.97M | $ -13.97M | -710.24% |
| 6/30/2024 | $ 4.09M | $ -14.04M | -342.92% |
| 3/31/2024 | $ 4.05M | $ -14.78M | -364.63% |
| 12/31/2023 | $ 8.27M | $ -13.98M | -169.06% |
| 9/30/2023 | $ 11.65M | $ -18.42M | -158.13% |
| 6/30/2023 | $ 14.71M | $ -19.32M | -131.39% |
| 3/31/2023 | $ 18.55M | $ -25.79M | -138.99% |
Key Performance Insights, Last 5 Years
- PREDICTIVE ONCOLOGY INC's latest trailing twelve months (TTM) ROE stands at -234.27%.
- Over the past 5 years, PREDICTIVE ONCOLOGY INC's average ROE has been -223.74%.
- The median ROE for PREDICTIVE ONCOLOGY INC during this period was -131.39%
- PREDICTIVE ONCOLOGY INC reached its highest ROE over the past 5 years at -46.7%.
- The lowest ROE recorded by PREDICTIVE ONCOLOGY INC in the same timeframe -1000.45%
PREDICTIVE ONCOLOGY INC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for PREDICTIVE ONCOLOGY INC is calculated as follows: Net Inc. Cmn. [ $ -28.67M ] / Equity [ $ 12.24M ]
(=) ROE [ -234.27% ] POAI - Return on Equity, Last 5 years
-1000.45%
Minimum
Dec 31, 2020
-46.7%
Maximum
Jun 30, 2021
-223.74%
Average
-131.39%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |